Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Seelos Therapeutics (SEEL) has a market cap of $214,970 Dollars USD. According to our data, Seelos Therapeutics is ranked No.9295 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $214,970 Dollars |
59.28%
|
| Dec 31, 2024 | $0.13 M |
-99.87%
|
| Dec 29, 2023 | $0.10 B |
-93.18%
|
| Dec 30, 2022 | $1.51 B |
-58.34%
|
| Dec 31, 2021 | $3.64 B |
3.16%
|
| Dec 31, 2020 | $3.53 B |
17.91%
|
| Dec 31, 2019 | $2.99 B |
-76.74%
|
| Dec 31, 2018 | $12.85 B |
-89.57%
|
| Dec 29, 2017 | $123.15 B |
41.54%
|
| Dec 30, 2016 | $87.01 B |
-86.87%
|
| Dec 31, 2015 | $662.66 B |
-1.00%
|
| Dec 31, 2014 | $669.35 B |
-62.26%
|
| Dec 31, 2013 | $1.774 T |
33.17%
|
| Dec 31, 2012 | $1.332 T |
-61.43%
|
| Dec 30, 2011 | $3.454 T |
48.70%
|
| Dec 31, 2010 | $2.323 T |
-18.78%
|
| Dec 31, 2009 | $2.860 T |
103.57%
|
| Dec 31, 2008 | $1.405 T |
-90.14%
|
| Dec 31, 2007 | $14.249 T |
111.94%
|
| Dec 29, 2006 | $6.723 T |
-12.99%
|
| Dec 30, 2005 | $7.727 T |
-48.67%
|
| Dec 31, 2004 | $15.052 T |
-62.41%
|
| Dec 31, 2003 | $40.038 T |
461.97%
|
| Dec 31, 2002 | $7.125 T |
-79.12%
|
| Dec 31, 2001 | $34.117 T |
-57.50%
|
| Dec 29, 2000 | $80.276 T |
93.94%
|
| Dec 31, 1999 | $41.392 T |
69.27%
|
| Dec 31, 1998 | $24.454 T |
62.47%
|
| Dec 31, 1997 | $15.052 T |
0.00%
|
| Dec 31, 1996 | $15.052 T |
140.00%
|
| Dec 29, 1995 | $6.272 T |
212.50%
|
| Dec 30, 1994 | $2.007 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
 Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
 Biohaven Pharmaceutical
BHVN
|
$4.10 B |
-0.000 M
|
USA
|
 Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
 ACADIA Pharmaceuticals
ACAD
|
$2.96 B |
-0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
 Vanda Pharmaceuticals
VNDA
|
$0.25 B |
-0.000 M
|
USA
|
 Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
 Otsuka Holdings
4578.T
|
$27.31 B |
-0.179 B
|
Japan
|
 Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
 Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
| Market Cap | = | SEEL Stock Price | * | SEEL Shares Outstanding |
| = | $0.02 | * | 0.58 M | |
| = | $214,970 Dollars |